This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Sylvia Santamarina-Fojo: Innovator in Nucleic Acid Regulation
Introduction
Sylvia Santamarina-Fojo is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of biotechnology, particularly in the regulation of genes associated with cholesterol metabolism.
Latest Patents
Sylvia holds a patent for a regulatory nucleic acid for the ABC1 gene. This invention addresses the transcription regulation of the ABC1 gene, which is linked to pathologies such as atherosclerosis. The patent also encompasses nucleotide constructs that encode polypeptides or nucleic acids of interest, controlled by the regulatory nucleic acid for the ABC1 gene. Additionally, it includes recombinant vectors, transformed host cells, and nonhuman transgenic mammals that incorporate this regulatory nucleic acid, along with methods for screening substances that can modify its activity.
Career Highlights
Sylvia is associated with Aventis Pharma S.A., where she applies her expertise in genetic regulation to advance therapeutic applications. Her work has the potential to impact treatments for diseases related to cholesterol metabolism.
Collaborations
Some of her notable coworkers include Marie-Françoise Rosier-Montus and Catherine Prades, who have collaborated with her on various projects in the field of biotechnology.
Conclusion
Sylvia Santamarina-Fojo's innovative work in nucleic acid regulation exemplifies the intersection of biotechnology and therapeutic development. Her contributions are paving the way for advancements in the treatment of cholesterol-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile